Skip to content
TrustList
New Science Ventures logo
Investor

New Science Ventures

Connecticut and London venture capital firm backing science-led life sciences and IT companies

New Science Ventures cover

About New Science Ventures

Life sciences holdings at clinical stage

New Science Ventures invests in life sciences companies whose work is at clinical stage. Novadip Biosciences is developing regenerative tissue products intended to speed the healing of large bone defects. NorthSea Therapeutics is developing structurally engineered fatty acids for non-alcoholic steatohepatitis and other metabolic diseases. Ventyx Biosciences focuses on oral therapies for inflammatory diseases, and Resolve Therapeutics is developing targeted therapies for autoimmune conditions.

Genome tools and analytical instruments

Cambridge Epigenetix describes itself as a life sciences tools and technology company working on genome sequencing. VUV Analytics makes the LUMA multi-channel vacuum ultraviolet absorbance detector, which the company says fits into existing laboratory workflows and offers best-in-class sensitivity. Holdings like these show the firm's interest in the tools scientists use every day, as well as in therapies.

Propulsion and information technology

The portfolio reaches into space as well. Phase Four builds radio-frequency thrusters for satellites and has described a plasma propulsion line for satellite manufacturers. The firm also invests in information technology companies that use novel science, and it describes its criteria as the same across life sciences and technology. Its stated focus is on significant unmet needs, which it treats as the test for any investment.

What each holding is trying to fix

Cambridge Epigenetix's tools are aimed at genome sequencing, and Novadip's products at regenerating tissue damaged by injury or disease. NorthSea's work centres on structurally engineered fatty acids for liver conditions linked to metabolism. Ventyx is developing an oral TYK2 inhibitor for inflammatory conditions, and Resolve Therapeutics is aiming at underserved autoimmune diseases with first-in-class therapies. VUV Analytics's LUMA detector is designed to integrate into existing laboratory work, which the company says it does with best-in-class sensitivity. Phase Four's propulsion work centers on radio-frequency thrusters that could give satellite makers a higher performance engine.

TrustList summary

New Science Ventures, or NSV, is a venture capital firm based in Connecticut and London. It invests in companies that use new scientific approaches, both at early and later stages, in life sciences and information technology.

Products and services

  • Early and late-stage investment: funding for companies at different points of growth.
  • Life sciences backing: holdings in areas such as genome sequencing tools, tissue regeneration, metabolic disease and inflammatory disease.
  • Information technology backing: support for science-led technology companies.
  • Portfolio examples: Cambridge Epigenetix, Novadip Biosciences, VUV Analytics, NorthSea Therapeutics, Ventyx Biosciences and Resolve Therapeutics.

Customers and markets

Companies that address significant unmet needs in life sciences and information technology through novel science.

Key facts

  • Based in: Connecticut, USA and London, UK
  • Focus sectors: Life sciences and information technology
  • Structure: Limited liability company

Summary written by TrustList from the business's own published information, Oct 2026.

Categories & features

Ask TrustList to introduce you to New Science Ventures

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of New Science Ventures

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about New Science Ventures.

New Science Ventures alternatives

Similar listings buyers compare against this one.

Chicago-based accelerator for technology companies serving the real estate industry

Semiconductor and display equipment maker that also invests in startups through venture and research programmes

Semiconductor and sensing company selling components and design tools to engineers in industrial, automotive and healthcare markets

Global startup accelerator and early-stage investor running city and sector programmes for founders

Venture arm of a crypto exchange investing in early-stage web3 and blockchain startups

Global software investor backing growth-stage technology companies with capital and in-house operating specialists

Venture capital firm linked to NTT that backs start-up founders through partnerships

Global aerospace accelerator and investor supporting start-ups from formation to acquisition